Results of a phase I study to determine the maximum tolerated dose of capecitabine when given concurrently with radical radiotherapy in the treatment of squamous cell carcinoma of the head and neck.
about
Interventions for preventing oral mucositis for patients with cancer receiving treatmentPhase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment.Review of current treatment practices for carcinoma of the head and neck.Capecitabine for treating head and neck cancer.Advances in oral delivery of anti-cancer prodrugs.
P2860
Results of a phase I study to determine the maximum tolerated dose of capecitabine when given concurrently with radical radiotherapy in the treatment of squamous cell carcinoma of the head and neck.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Results of a phase I study to ...... arcinoma of the head and neck.
@en
Results of a phase I study to ...... arcinoma of the head and neck.
@nl
type
label
Results of a phase I study to ...... arcinoma of the head and neck.
@en
Results of a phase I study to ...... arcinoma of the head and neck.
@nl
prefLabel
Results of a phase I study to ...... arcinoma of the head and neck.
@en
Results of a phase I study to ...... arcinoma of the head and neck.
@nl
P2093
P1476
Results of a phase I study to ...... carcinoma of the head and neck
@en
P2093
Andrew J Sykes
Janet A D Ironside
Kathleen L Mais
Robert H MacDougall
P356
10.1016/J.RADONC.2004.02.001
P577
2004-04-01T00:00:00Z